 Deal No 27.94 net shares | 15.0¢ / 28.0¢ | -$2.5 (-41.7%) | $3.91 13.97 shares | Apr 27, 2026 1:53 PM | |
 Dplus Challengers Yes 40.00 net shares | 20.0¢ / 18.0¢ | -$8 (-100.0%) | $3.6 20.00 shares | Apr 24, 2026 2:16 PM | |
 110M–130M Yes 40.00 net shares | 13.0¢ / 12.0¢ | -$5.2 (-100.0%) | $2.4 20.00 shares | Apr 22, 2026 5:08 AM | |
 Kim David Yes 40.00 net shares | 12.0¢ / 11.0¢ | -$4.8 (-100.0%) | $2.2 20.00 shares | Apr 27, 2026 3:27 PM | |
 ↓ $4,700 No 40.00 net shares | 17.0¢ / 6.0¢ | -$9.6 (-70.6%) | $1.2 20.00 shares | Apr 27, 2026 9:42 AM | |
 125M–140M Yes 40.00 net shares | 2.0¢ / 5.9¢ | -$0.8 (-100.0%) | $1.18 20.00 shares | Apr 25, 2026 1:35 AM | |
 19-20.5m Yes 76.80 net shares | 2.1¢ / 1.5¢ | -$1.61 (-100.0%) | $0.75 50.00 shares | Apr 27, 2026 6:51 AM | |
>20.5m No 100.00 net shares | 6.0¢ / 0.2¢ | -$6 (-100.0%) | $0.1 50.00 shares | Apr 27, 2026 5:57 AM | |
 Mejia 30-35% Yes 40.00 net shares | 1.0¢ / 0.1¢ | -$0.4 (-100.0%) | $0.02 20.00 shares | Apr 17, 2026 11:12 PM | |
 May 31 Yes 0.02 net shares | 30.0¢ / 100.0¢ | -$0.01 (-0.6%) | $0.01 0.01 shares | Apr 22, 2026 10:43 PM | |
 Jeremiyah Love Yes 0.01 net shares | 28.5¢ / 100.0¢ | $2.19 (7.6%) | $0.01 0.01 shares | Apr 24, 2026 12:09 AM | |
 April 21 No 0.01 net shares | 35.7¢ / 99.9¢ | $4.25 (19.9%) | $0.01 0.01 shares | Apr 10, 2026 11:06 PM | |
 FDA approves Sanofi's Tzield? Yes 0.01 net shares | 41.0¢ / 100.0¢ | $0.84 (12.1%) | $0 0.00 shares | Apr 21, 2026 7:28 PM | |
 Hal Finney No 0.01 net shares | 41.5¢ / 100.0¢ | -$8.2 (-12.3%) | $0 0.00 shares | Apr 20, 2026 8:16 PM | |
FDA approves Grace Therapeutics’ GTx-104? No 0.01 net shares | 28.0¢ / 100.0¢ | $0.58 (6.9%) | $0 0.00 shares | Apr 18, 2026 7:43 AM | |
 April 20 No 0.01 net shares | 28.0¢ / 100.0¢ | $1.25 (5.6%) | $0 0.00 shares | Apr 17, 2026 9:45 PM | |
 Vitality No 0.02 net shares | 47.6¢ / 43.0¢ | -$3.41 (-5.2%) | $0 0.01 shares | Apr 20, 2026 8:17 AM | |
 25-49 No 20.02 net shares | 35.6¢ / 50.1¢ | -$4.28 (-8.1%) | $0 0.01 shares | Apr 25, 2026 2:35 PM | |
Arvell Reese No 0.01 net shares | 29.9¢ / 100.0¢ | $9.4 (9.2%) | $0 0.00 shares | Apr 24, 2026 12:00 AM | |
 Matt Claman Yes 0.01 net shares | 18.0¢ / 41.0¢ | $0.02 (10.5%) | $0 0.01 shares | Apr 9, 2026 11:03 PM | |
April 22 No 0.00 net shares | 35.0¢ / 99.8¢ | -$0.4 (-2.9%) | $0 0.00 shares | Apr 20, 2026 10:41 PM | |
FDA approves Sanofi’s Subcutaneous Sarclisa? No 0.00 net shares | 35.7¢ / 99.0¢ | -$12.5 (-38.9%) | $0 0.00 shares | Apr 22, 2026 10:09 AM | |
 Strait of Hormuz traffic returns to normal by May 15? Yes 0.02 net shares | 19.0¢ / 18.0¢ | $0.44 (5.7%) | $0 0.01 shares | Apr 24, 2026 12:15 AM | |
 NVIDIA No -5.51 net shares | 43.0¢ / 24.0¢ | $2.04 (85.8%) | $0 0.01 shares | Mar 30, 2026 5:54 PM | |
 December 31, 2026 Yes 0.01 net shares | 36.4¢ / 20.0¢ | -$1 (-2.8%) | $0 0.01 shares | Apr 13, 2026 7:51 PM |
1–25
